QUIDELORTHO CORP (QDEL) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-28..
Gross margin
Overview →Financial period ending 2026-06-28; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-28. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 2.67B USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-28 | (m) | $2.67B | (m) | (m) |
| 2026-03-29 | (m) | $2.66B | (m) | (m) |
| 2025-12-28 | (m) | $2.73B | (m) | (m) |
| 2025-09-28 | (m) | $2.71B | (m) | (m) |
| 2025-06-29 | (m) | $2.74B | (m) | (m) |
| 2025-03-30 | (m) | $2.76B | (m) | (m) |
| 2024-12-29 | (m) | $2.78B | (m) | (m) |
| 2024-09-29 | (m) | $2.82B | (m) | (m) |
| 2024-06-30 | (m) | $2.83B | (m) | (m) |
| 2024-03-31 | (m) | $2.86B | (m) | (m) |
| 2023-12-31 | (m) | $3.00B | (m) | (m) |
| 2023-10-01 | (m) | $3.12B | (m) | (m) |
| 2023-07-02 | (m) | $3.16B | (m) | (m) |
| 2023-04-02 | (m) | $3.11B | (m) | (m) |
| 2023-01-01 | (m) | $3.27B | (m) | (m) |
| 2022-10-02 | (m) | (m) | (m) | (m) |
| 2022-07-03 | (m) | (m) | (m) | (m) |
| 2022-04-03 | (m) | (m) | (m) | (m) |
| 2022-01-02 | (m) | $1.70B | (m) | (m) |
| 2021-10-03 | (m) | (m) | (m) | (m) |
| 2021-07-04 | (m) | (m) | (m) | (m) |
| 2021-01-03 | (m) | $1.66B | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |